SelectScience InterviewsSpectroscopy

QTOF Mass Spectrometry: Screening for Designer Drugs in Toxicological Samples

20 Jul 2015
QTOF Mass Spectrometry: Screening for Designer Drugs in Toxicological Samples

Learn about the use of QTOF technology for screening toxicology samples for designer drugs. In the absence of known targets, scientists must use non-targeted and semi-targeted screening methods to screen for drug fragments predicted from models of existing designer drugs.

Xevo G2-XS QTof

Waters

Xevo G2-XS QTof - eXtreme Sensitivity, eXtraordinary Selectivity, eXceptional Solutions. For the scientist who needs to identify, quantify and confirm the broadest range of compounds in the most complex and challenging samples the Xevo G2-XS QTof provides maximum robustness with no compromise in performance, class-leading real-world quantitative sensitivity, the highest quality, most comprehensive qualitative information, flexibility to adapt to changing needs and is accessible to experts and non-experts alike.

(17)

Xevo G2-XS ToF

Waters

Xevo G2-XS Tof - Performance, robustness, and flexibility made accessible to everyone. For the scientist who needs to identify, quantify and confirm the broadest range of compounds in the most complex and challenging samples the Xevo G2-XS Tof provides maximum robustness with no compromise in performance, the highest quality, most comprehensive qualitative and quantitative information, flexibility to adapt to changing needs, and is accessible to experts and non-experts alike.

(1)

Other videos from SelectScience

Links

QTOF Mass Spectrometry: Screening for Designer Drugs in Toxicological Samples